Irras Ab (0GDW) Quote

What a pathetic flailing blowhard you are, Proto. As an LWLG prognosticator, you have proven yourself to be abysmal. Wrong about everything, time and time again, for 20 years.

There is nothing wrong here that a 1:5000 reverse split won't fix. Get ready!

If we break 531, 447 is the next main trend low test. Very scary times ahead.

Vance accuses Harris of not doing her job at border. Didn’t the Republicans vote against a border solution in the house couple of times 😁

So why is this not a winner?

If the probe becomes a case we're talking many many years. It shouldn't become a case as Nvidia has many existing and new competitors. Just because they have had enormous success in the past 18 months doesn't mean that we (the government) should punish them for it.
The latest news from Apple,

Here's two recent examples proving that NDA's do work and when the Tier 1 deals or other significant news the stock price will move quickly to the 20 high and more!

1) ASTS was in the 2's in May 2024 when it announced a deal with AT&T, the stock made it's way to 20's already

looks like 4.95 :o)

lets roll:o)

HE should be disqualified or worse...
Put him in the ring with Tyrus (love that guy) and give him a taste of his own medicine.
https://nypost.com/wp-content/uploads/sites/2/2024/08/Front-cover-08-02-20

Nvidia shares fall 2% in Frankfurt after media report of US probe
02:18:29 AM ET, 08/02/2024 - Reuters
LONDON, Aug 2 (Reuters) - Nvidia shares fell 2.3% in Frankfurt on Friday, following media reports of the U.S. government launching an antitrust probe into the company following compla

interesting story

Planted bomb, remote control and AI: How the Mossad killed Hamas' leader in Iran

https://www.msn.com/en-us/news/world/planted-bomb-remote-control-and-ai-how-the-mossad-killed-hamas-leader-in-iran/ar-BB1r2ceH?ocid=msedgntp&pc=HCTS&cvid=35dc997a862a481f9

Collegium Pharmaceutical, Inc. (NASDAQ:COLL - Free Report) - Stock analysts at HC Wainwright reduced their FY2024 earnings estimates for Collegium Pharmaceutical in a research note issued on Tuesday, July 30th. HC Wainwright analyst O. Livnat now forecasts that the specialty pharmaceutical company w

Convertible Note Transaction with Certain Investors




On August 1, 2024, the Company entered into Convertible Note Purchase Agreements (“Purchase Agreements”) with certain investors (the “Investors”). On August 2, 2024, the Company issued to each Investor an Uns

VSEE..ROBOTS EXPLODING IN THE AFTER MARKET...WATCHING CLOSELY

Eloquently encapsulated, Rayo!


Your problem is that your desires shape your truth, and reality shapes mine.

Powered by one of the most robust and comprehensive data engines in the world,
we are setting the standard for the accuracy and credibility of information.

Get out the vomit bag.

Good job and well done.

SNDL Reports Second Quarter 2024 Financial and Operational Results

https://sndl.com/news/news-details/2024/SNDL-Reports-Second-Quarter-2024-Financial-and-Operational-Results/default.aspx